Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31730152.
- Also identified by DOI 10.1001/jama.2019.18587 and PMC identifier PMC6823105.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers.